Prostate Cancer - Results from #60

Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review. January 20, 2023

Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer. January 20, 2023

Clinical performance of MRI & biomarkers for prostate cancer diagnosis in men at high genetic risk. January 20, 2023

Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval. January 20, 2023

Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy. January 19, 2023

Interobserver Reproducibility of Cribriform Cancer in Prostate Needle Biopsies and Validation of International Society of Urological Pathology Criteria. January 19, 2023

Automated deep-learning system in the assessment of MRI-visible prostate cancer: comparison of advanced zoomed diffusion-weighted imaging and conventional technique. January 19, 2023

Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging. January 19, 2023

CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. January 19, 2023

The next generation of evidence-based medicine. January 19, 2023

Analysis of the financial impact and efficiency of the One Stop Prostate Clinic: A same day prostate cancer diagnostic clinic in the Australian public health system. January 18, 2023

Same day discharge for robot-assisted radical prostatectomy: a prospective cohort study documenting an Australian approach. January 18, 2023

Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer. January 18, 2023

Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: a retrospective bicenter study by the SFRO Brachytherapy Group. January 18, 2023

Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy. January 18, 2023

Validation of a surface-based deformable MRI-3D ultrasound image registration algorithm toward clinical implementation for interstitial prostate brachytherapy. January 17, 2023

Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate Cancer. January 17, 2023

Applications of artificial intelligence in prostate cancer histopathology. January 17, 2023

PSMA-PET/CT guided intensification of radiotherapy for prostate cancer (PSMAgRT): Findings of detection rate, impact on cancer management, and early toxicity from a phase 2 randomised controlled trial. January 17, 2023

A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer. January 17, 2023

Page 4 of 1276

email news signup